Publication & Citation Trends
Publications
0 total
Advancements in intratumoral therapies for liver tumors
Cited by 0
Semantic Scholar
Abstract PS5-08-03: Denali-1: a seamless phase 1/2 study of A2B395, a logic-gated, allogeneic, Tmod chimeric antigen receptor T-cell (CAR T) therapy, in patients with triple-negative breast cancer and other EGFR-expressing solid tumors with HLA-A*02 loss of heterozygosity (LOH)
Cited by 1
Semantic Scholar
LBA30 Zanzalintinib plus atezolizumab (zanza + atezo) vs regorafenib (rego) in patients (pts) with previously treated metastatic colorectal cancer (mCRC): Primary overall survival (OS) analysis from the randomized, open-label, phase III STELLAR-303 study
Cited by 0
Semantic Scholar
1558P Mitigating infusion-related reactions (IRRs) with cetirizine and montelukast in patients (pts) receiving REGN7075, an EGFR×CD28 bispecific antibody (bsAb)
Cited by 0
Semantic Scholar
Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities OA
Cited by 11
Semantic Scholar
Improving ethnic and racial diversity in biomarker-driven clinical trials: A proof of concept with the BASECAMP-1 master prescreening study of patients with high-risk solid tumors with human leukocyte antigen-A*02 (HLA-A*02) loss of heterozygosity (LOH).
Cited by 1
Semantic Scholar
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
Cited by 97
Semantic Scholar
Next generation sequencing (NGS) to identify relapsed gastrointestinal (GI) solid tumor patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) for future logic-gated CAR T therapy to reduce on target off tumor toxicity.
Cited by 0
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(83)
Gastric Cancer Management and Outcomes
(34)
CAR-T cell therapy research
(33)
Cancer Treatment and Pharmacology
(28)
Lung Cancer Treatments and Mutations
(25)
Affiliations
Northwestern University
Ontario Institute for Cancer Research
Santa Monica College
Novartis (Switzerland)
Fox Chase Cancer Center